Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis.
Hyun Jin SongXinyi JiangLinda HenryMindie H NguyenHaesuk ParkPublished in: European journal of clinical pharmacology (2020)
PPI use was associated with an increased risk of HCC and mortality in patients with CLD suggesting that PPI prescriptions in patients with CLD should be considered carefully.